REDUCED SERUM 1,25‐(OH)2 VITAMIN D3 LEVELS IN PREDNISONE‐TREATED ADOLESCENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS
- 1 March 1979
- journal article
- research article
- Published by Wiley in Acta Paediatrica
- Vol. 68 (2), 109-111
- https://doi.org/10.1111/j.1651-2227.1979.tb04969.x
Abstract
The serum levels of 1,25-(OH)2 vitamin D3 were assayed in samples from 12 adolescent patients with SLE. Subnormal levels were observed in 7 of these 12 patients. Low levels of the metabolically active polar metabolite of vitamin D3 may contribute to the development of osteopenia observed in this disease. The cumulative effects of the osteoporotic and anti vitamin D effects of long term steroid therapy in children with SLE may require the cautious administration of supplemental vitamin D.Keywords
This publication has 8 references indexed in Scilit:
- Intestinal Calcium Absorption in Exogenous HypercortisonismJournal of Clinical Investigation, 1977
- Osteopenia in patients with rheumatic diseases: Principles of diagnosis and therapySeminars in Arthritis and Rheumatism, 1976
- 1,25-Dihydroxyvitamin D in Biological Fluids: A Simplified and Sensitive AssayScience, 1976
- The Effect of Prednisolone® upon the Metabolism and Action of 25-Hydroxy and 1,25-Dihydroxyvitamin D 3Proceedings of the National Academy of Sciences, 1974
- Avascular necrosis of bone in systemic lupus erythematosusThe Journal of Pediatrics, 1974
- Vitamin D and Intestinal Transport of Calcium: Effects of PrednisoloneEndocrinology, 1973
- Lupus erythematosus and avascular bone necrosis: A clinical study of three cases and review of the literatureArthritis & Rheumatism, 1962
- Avascular (Aseptic) Bone Necrosis Associated with Systemic Lupus ErythematosusPublished by American Medical Association (AMA) ,1960